Iyo Bank Ltd. Buys New Stake in Danaher Corporation $DHR

Iyo Bank Ltd. purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to its most recent filing with the SEC. The fund purchased 4,328 shares of the conglomerate’s stock, valued at approximately $3,116,000. Danaher comprises about 0.9% of Iyo Bank Ltd.’s portfolio, making the stock its 28th largest holding.

Several other hedge funds have also bought and sold shares of DHR. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher in the second quarter worth about $25,000. JPL Wealth Management LLC bought a new position in Danaher during the third quarter valued at approximately $25,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in Danaher during the 4th quarter valued at approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Guggenheim cut their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Argus decreased their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Finally, Citigroup began coverage on shares of Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

View Our Latest Analysis on Danaher

Danaher Trading Up 1.6%

Shares of NYSE DHR opened at $219.42 on Friday. The business’s 50 day moving average is $195.80 and its two-hundred day moving average is $192.61. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the company earned $0.77 EPS. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.